Page 2 - Advanced Care Scripts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biogen Agrees To Pay $22 Mln To Settle Kickback Allegations WESTON (dpa-AFX) - Biogen has agreed to pay $22 million to settle allegations that it illegally using foundations as a conduit to pay the copays of Medicare patients taking the company's multiple sclerosis drugs, the U.S. Justice Department said. Advanced Care Scripts, a pharmacy company that worked with Biogen, agreed to pay $1.4 million to settle the allegation. The whistleblower will receive about $3.96 million of the settlement, the Justice department said. Under the Anti-Kickback Statute, a pharmaceutical company is prohibited ...

The Biogen pharmaceutical company on Thursday agreed to pay $22 million to resolve allegations that it illegally paid insurance co-payments for thousands of patients in order to collect Medicare revenue, federal prosecutors said. The company was accused of channeling money through two nonprofit foundations to cover co-payments for patients who were using Biogen drugs used to treat multiple sclerosis. Prosecutors said Biogen identified patients who were in its free drug program for low-income patients but were eligible for Medicare benefits. Biogen then conspired with a pharmacy company to get...

December 17, 2020 BOSTON (AP) — The Biogen pharmaceutical company on Thursday agreed to pay $22 million to resolve allegations that it illegally paid insurance co-payments for thousands of patients in order to collect Medicare revenue, federal prosecutors said. The company was accused of channeling money through two nonprofit foundations to cover co-payments for patients who were using Biogen drugs used to treat multiple sclerosis. Prosecutors said Biogen identified patients who were in its free drug program for low-income patients but were eligible for Medicare benefits. Biogen then conspi...

ADVERTISEMENT ADVERTISEMENT Biogen To Pay $22M To Resolve Drug Kickback Claims Law360 (December 17, 2020, 4:29 PM EST) -- Biogen Inc. will pay $22 million to resolve allegations that it illegally used two foundations to pay Medicare co-pays for patients taking the company's multiple sclerosis drugs, becoming the latest in a line of pharmaceutical companies to settle kickback claims. Announcing the civil settlement Thursday, the Boston U.S. attorney's office alleged Biogen ran afoul of the False Claims Act by using the Chronic Disease Fund and the Assistance Fund to take care of co-pays for ...

Pharma Giant And Speciality Pharmacy Settle Case Alleging False Claims Violations News provided by Share this article Share this article BOSTON, Dec. 17, 2020 /PRNewswire/ -- One of the world's largest pharmaceutical companies, Biogen, Inc., and a large specialty pharmacy, Advanced Care Scripts, Inc. (ACS), will pay a combined $23.4 million to settle allegations under the Federal False Claims Act that kickbacks were used to induce the sale of drugs used to treat multiple sclerosis. Biogen will pay $22 million and ACS will pay $1.4 million. The settlement was reached in United States of Ameri...